Leadership Transition at PharmaCorp
PharmaCorpRx Inc. has made significant changes to its executive leadership team that signal a new chapter for the organization. As of December 1, 2025, Paul Dale will transition into the role of President and Chief Operating Officer. This change comes as Calvin LeRoux steps down from his position as President and takes on a one-year role as Strategic Advisor to the Chief Executive Officer.
Paul Dale Steps Up
Paul Dale has been instrumental in the success of PharmaCorp since its inception, successfully serving as the Chief Operating Officer. His promotion marks an important step forward as the company seeks to implement its national expansion strategy. Alan Simpson, Executive Chairman of PharmaCorp, expressed confidence in Dale's leadership abilities, noting his extensive experience in managing retail organizations and his successful track record with acquisitions and integrations within the pharmaceutical sector.
Calvin LeRoux Transitions to Advisory Role
As Calvin LeRoux concludes his tenure as President, his new position as Strategic Advisor will enable him to facilitate a smooth transition and continue to guide the company on strategic initiatives. Alan Simpson praised LeRoux for his pivotal role in the early development of PharmaCorp and his efforts in solidifying PharmaCorp's relationship with PharmaChoice Canada, stating that his continued support in the advisory role will greatly benefit the organization.
Welcoming Sophia Sigler as Director of Business Development
In line with these leadership changes, PharmaCorp is thrilled to announce the appointment of Sophia Sigler as the new Director of Business Development, starting December 1, 2025. Sigler will take charge of the company’s business development initiatives. Her responsibilities will include identifying acquisition opportunities, managing the transaction pipeline, coordinating due diligence efforts, and offering support to pharmacist partners regarding co-ownership and succession strategies.
About PharmaCorp Rx Inc.
PharmaCorp has positioned itself as a leading Canadian pharmacy acquisition and ownership platform, focusing on empowering pharmacists by transforming them into equity partners. The company supports retiring pharmacy owners through various strategic initiatives. By leveraging capital, operational expertise, and strategic support, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada banner. Currently, the company operates seven pharmacies under this brand and has ongoing plans to acquire both bannered and independent pharmacies across the country. This includes rebranding non-bannered locations under the PharmaChoice Canada network in alignment with its strategic alliance.
Engaging with Pharmacy Owners
PharmaCorp is keen on engaging with pharmacy owners who are considering succession plans or are looking to sell their businesses. The company aims for seamless transitions that not only protect the legacy of the pharmacy owners but also serve the community effectively. Potential discussions can help pharmacy owners explore their options. For detailed information regarding the acquisition program and processes, stakeholders are encouraged to reach out directly.
Contact Information
For any inquiries or further information, you can get in touch with PharmaCorp’s Investor Relations at info@pharmacorprx.ca. You can also reach out by phone at (306) 536-3771 for confidential discussions.
Frequently Asked Questions
What leadership changes were announced at PharmaCorp?
PharmaCorp announced the appointment of Paul Dale as President and COO, with Calvin LeRoux moving to an advisory role. Sophia Sigler will join as Director of Business Development.
What are Paul Dale's new responsibilities?
As President and COO, Paul Dale will lead the implementation of PharmaCorp's national expansion strategy and oversee broader leadership duties.
What role will Calvin LeRoux play moving forward?
Calvin LeRoux will act as Strategic Advisor to the CEO, assisting in the transition and continuing to contribute to key strategic initiatives.
Who is Sophia Sigler?
Sophia Sigler is the newly appointed Director of Business Development, responsible for leading acquisition initiatives and supporting pharmacist partners.
How does PharmaCorp support pharmacy owners?
PharmaCorp empowers pharmacy owners by providing capital and strategic support to facilitate smooth transitions, helping them secure their legacies while enhancing community services.
